PDL BioPharma - 28 Year Stock Price History | PDLI

Historical daily share price chart and data for PDL BioPharma since 1992 adjusted for splits. The latest closing stock price for PDL BioPharma as of December 30, 2020 is 2.47.
  • The all-time high PDL BioPharma stock closing price was 81.83 on March 07, 2000.
  • The PDL BioPharma 52-week high stock price is 2.84, which is 15% above the current share price.
  • The PDL BioPharma 52-week low stock price is 2.09, which is 15.4% below the current share price.
  • The average PDL BioPharma stock price for the last 52 weeks is 2.46.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
PDL BioPharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.0033 3.2100 3.7400 2.1500 2.4700 -23.88%
2019 3.0441 2.9100 3.8500 2.1250 3.2450 11.90%
2018 2.6808 2.8700 3.1200 2.2800 2.9000 5.84%
2017 2.5926 2.2300 3.5100 1.9800 2.7400 29.25%
2016 3.1052 3.4600 3.8200 1.9800 2.1200 -40.11%
2015 5.9458 7.6800 7.7200 3.5000 3.5400 -54.09%
2014 8.6706 8.5400 10.2600 7.3250 7.7100 -8.65%
2013 7.8466 7.3400 10.1000 6.6500 8.4400 19.89%
2012 6.8889 6.1700 8.3700 6.0200 7.0400 13.55%
2011 5.8654 6.3600 6.6400 4.6900 6.2000 -0.48%
2010 6.0019 6.8800 7.2900 5.0500 6.2300 -9.18%
2009 7.4671 6.2500 9.2200 5.2200 6.8600 11.00%
2008 11.2088 17.1300 17.1300 5.8600 6.1800 -64.73%
2007 21.7338 20.0800 27.7000 16.5100 17.5200 -13.01%
2006 23.1031 28.4400 32.8000 16.5100 20.1400 -29.13%
2005 22.3211 20.2900 29.9200 13.8500 28.4200 37.56%
2004 20.0167 18.4200 27.1400 15.1000 20.6600 15.42%
2003 12.1830 9.0000 18.9200 6.9800 17.9000 110.59%
2002 13.4336 31.4900 31.4900 7.4000 8.5000 -74.09%
2001 30.6898 39.1250 45.1950 17.3750 32.8000 -24.49%
2000 40.3184 17.3125 81.8250 14.8825 43.4400 148.23%
1999 6.8298 6.0950 18.1875 3.3600 17.5000 202.64%
1998 7.0679 10.0325 11.5625 4.1875 5.7825 -41.64%
1997 8.9101 8.5000 12.7825 6.2825 9.9075 8.58%
1996 5.9484 5.6875 9.4375 3.5000 9.1250 57.80%
1995 4.6175 4.0000 6.2200 3.4700 5.7825 46.86%
1994 5.2120 5.8125 7.4075 3.5000 3.9375 -35.05%
1993 3.2286 2.9075 6.5625 1.6250 6.0625 104.12%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86